Possible autoimmune mechanisms of regulation of rat behavior in the “open field” test

Abstract

BACKGROUND: In recent years, researchers have demonstrated interest in the autoimmune mechanisms of regulation of physiological processes. In response to damage or protein expression, the levels of autoantibodies increased to ensure the restoration of the disturbed balance. Levels of autoantibodies are high in many diseases.

AIM: The aim of this study was to assess the levels of autoantibodies in the blood serum of experimental animals and evaluate their behavior in the “open field” test.

MATERIALS AND METHODS: Of 32 male rats, two groups were formed: group 1 was not exposed to stress, whereas group 2 was subjected to stress for 7 days by applying a clamp on the skin fold for 15 min daily. Three days after the last stress procedure, testing was conducted in the “open field.” After assessing the behavior, blood serum was obtained, and the levels of autoantibodies to dopamine receptors (DR1 and DR2) and NMDA receptors (NR1, NR2A, and NR2B) were determined.

RESULTS: Compared with group 1, group 2 visited the central zones of the field less often, had lower vertical activity, and less often performed acts of washing. In group 2, the levels of autoantibodies to DR1 and DR2 were higher, but to NR2B were lower. Correlation analysis revealed that in group 2, the level of autoantibodies to DR2 was associated with horizontal activity (r = –0.60). In group 1, a relationship was established between the level of autoantibodies to NR2B and the number of runs through the central zones of the field (r = +0.68).

CONCLUSIONS: Taking into account the revealed relationship between the levels of autoantibodies and activity in the open field, the degree of increase in blood IgG titers to DR2 receptors may reflect the severity of changes in the behaviors of animals under stress. Conversely, in connection with the emerging data on the possibility of IgG penetration through the blood–brain barrier, the effect of autoantibodies on brain dopamine receptors with a limited activity of the dopaminergic system may be considered.

Keywords

rats / open field test / autoantibodies / dopamine receptors / NMDA receptors

References

[1] Baturin VA, Kostrovskaya MV, Grudina EV, et al. Evalution of the neurospecific autoantibodies level in patients with COVID-19: preliminary report. Medical News of North Caucasus. 2021;16(1):66–67. (In Russ.) DOI: 10.14300/mnnc.2021.16017

[2] Батурин В.А., Костровская М.В., Грудина Е.В., и др. Определение уровня нейроспецифических аутоантител у больных COVID-19: предварительное сообщение // Медицинский вестник Северного Кавказа. 2021. Т. 16, № 1. С. 66–67. DOI: 10.14300/mnnc.2021.16017

[3] Baturina MV, Beyer EV, Baturin VA, Popov AV. Dependence of the severity of haloperidol catalepsy on the activity of dopaminergic and glutamatergic systems of the brain of rats with prolonged use of antipsychotics. Medical News of North Caucasus. 2020;15(3):307–310. (In Russ.) DOI: 10.14300/mnnc.2020.15073

[4] Батурина М.В., Бейер Э.В., Батурин В.А., Попов А.В. Зависимость выраженности галоперидоловой каталепсии от активности дофаминергической и глутаматергической систем мозга крыс при длительном введении нейролептиков // Медицинский вестник Северного Кавказа. 2020. Т. 15, № 3. С. 307–310. DOI: 10.14300/mnnc.2020.15073

[5] Еrmakov SV, Mozheiko RA, Baturin VA, Belokon OS. S-100 protein autoantibody level as a possible outcome predictor in acute stroke. The bulletin of contemporary clinical medicine. 2018;11(6):11–15. (In Russ.) DOI: 10.20969/VSKM.2018.11(6).11-15

[6] Ермаков С.В., Можейко Р.А., Батурин В.А., Белоконь О.С. Уровень аутоантител к белку S-100 — возможный предиктор исходов острого нарушения мозгового кровообращения // Вестник современной клинической медицины. 2018. Т. 11, № 6. С. 11–15. DOI: 10.20969/VSKM.2018.11(6).11-15

[7] Baturin VA, Baturina MV, Mamtseva GI, et al. Levels of neurotropic autoantibodies in patients with schizophrenia. Medical News of North Caucasus. 2016;11(2):176–178. DOI: 10.14300/mnnc.2016.11030

[8] Baturin V.A., Baturina M.V., Mamtseva G.I., et al. Levels of neurotropic autoantibodies in patients with schizophrenia // Medical news of North Caucasus. 2016. Vol. 11, No. 2. P. 176–178. DOI: 10.14300/mnnc.2016.11030

[9] Pollak TA, Beck K, Irani SR, et al. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology. 2016;233:1605–1621. DOI: 10.1007/s00213-015-4156-y

[10] Pollak T.A., Beck K., Irani S.R., et al. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications // Psychopharmacology. 2016. Vol. 233. P. 1605–1621. DOI: 10.1007/s00213-015-4156-y

RIGHTS & PERMISSIONS

Baturin V.A., Beyer E.V., Baturina M.V.